Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Yamout

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2020
Serum vitamin D level is associated with speed of processing in multiple sclerosis patientsHala Darwish, Natali Farran, Salem Hannoun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis and Related Disorders|May 19, 2026
Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE ExperienceBassem Yamout, Ahmad Shatila, Jihad Inshasi, et al.
Therapeutic Advances in Neurological Disorders|July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practicePer Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Journal of Neuroimmunology|April 7, 2016
Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot studyBassem Yamout, Nathalie M Karaky, Rami A R Mahfouz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2010
Extracranial venous stenosis is an unlikely cause of multiple sclerosisBassem Yamout, Aline Herlopian, Zeinab Issa, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Neurodegenerative Disease Management|October 24, 2022
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summaryPeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 15, 2025
Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experienceMaya Zeineddine, Ghida Ismail, Malak Issa, et al.
Multiple Sclerosis and Related Disorders|February 13, 2025
The awareness and knowledge of multiple sclerosis patients about their disease: A Lebanese cross-sectional studyMaya Zeineddine, Malak Issa, Ghida Ismail, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2020
Serum vitamin D level is associated with speed of processing in multiple sclerosis patientsHala Darwish, Natali Farran, Salem Hannoun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis and Related Disorders|May 19, 2026
Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE ExperienceBassem Yamout, Ahmad Shatila, Jihad Inshasi, et al.
Therapeutic Advances in Neurological Disorders|July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practicePer Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Journal of Neuroimmunology|April 7, 2016
Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot studyBassem Yamout, Nathalie M Karaky, Rami A R Mahfouz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2010
Extracranial venous stenosis is an unlikely cause of multiple sclerosisBassem Yamout, Aline Herlopian, Zeinab Issa, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Neurodegenerative Disease Management|October 24, 2022
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summaryPeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 15, 2025
Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experienceMaya Zeineddine, Ghida Ismail, Malak Issa, et al.
Multiple Sclerosis and Related Disorders|February 13, 2025
The awareness and knowledge of multiple sclerosis patients about their disease: A Lebanese cross-sectional studyMaya Zeineddine, Malak Issa, Ghida Ismail, et al.
Pageof 9